File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Global innovation generation and financial performance in business-to-business relationships: The case of cross-border alliances in the pharmaceutical industry
  • Basic View
  • Metadata View
  • XML View
TitleGlobal innovation generation and financial performance in business-to-business relationships: The case of cross-border alliances in the pharmaceutical industry
 
AuthorsSivakumar, K4
Roy, S1
Zhu, J2
Hanvanich, S3
 
KeywordsBusiness-to-business relationships
Financial performance
Global innovation generation
Pharmaceutical industry
Strategic alliances
 
Issue Date2011
 
PublisherSpringer Netherlands
 
CitationJournal Of The Academy Of Marketing Science, 2011, v. 39 n. 5, p. 757-776 [How to Cite?]
DOI: http://dx.doi.org/10.1007/s11747-010-0229-y
 
AbstractThe past few decades have witnessed a significant increase in the number of cross-border strategic alliances among firms. We focus on the role of alliance expertise (alliance experience and diversity of partners) and alliance governance (horizontal vs. vertical alliances and joint venture vs. other alliances) in global innovation generation. We also examine the effect of these variables on the financial performance of the focal firm. The conceptual model is tested using an empirical analysis of cross-border alliances formed by U. S. pharmaceutical companies from 1985 to 2008. We find that while prior alliance experience has a positive association with global innovation generation, diversity of partners has a negative relationship. In addition, whether the alliance is horizontal or vertical has no bearing on the innovation generation, but joint ventures are associated with more global innovation generation than other types of alliances. Finally, as global innovation generation increases, financial performance increases up to a point but thereafter exhibits a negative relationship. © 2010 The Author(s).
 
ISSN0092-0703
2013 Impact Factor: 3.410
2013 SCImago Journal Rankings: 3.022
 
DOIhttp://dx.doi.org/10.1007/s11747-010-0229-y
 
ISI Accession Number IDWOS:000294353600007
 
ReferencesReferences in Scopus
 
DC FieldValue
dc.contributor.authorSivakumar, K
 
dc.contributor.authorRoy, S
 
dc.contributor.authorZhu, J
 
dc.contributor.authorHanvanich, S
 
dc.date.accessioned2012-02-21T05:44:45Z
 
dc.date.available2012-02-21T05:44:45Z
 
dc.date.issued2011
 
dc.description.abstractThe past few decades have witnessed a significant increase in the number of cross-border strategic alliances among firms. We focus on the role of alliance expertise (alliance experience and diversity of partners) and alliance governance (horizontal vs. vertical alliances and joint venture vs. other alliances) in global innovation generation. We also examine the effect of these variables on the financial performance of the focal firm. The conceptual model is tested using an empirical analysis of cross-border alliances formed by U. S. pharmaceutical companies from 1985 to 2008. We find that while prior alliance experience has a positive association with global innovation generation, diversity of partners has a negative relationship. In addition, whether the alliance is horizontal or vertical has no bearing on the innovation generation, but joint ventures are associated with more global innovation generation than other types of alliances. Finally, as global innovation generation increases, financial performance increases up to a point but thereafter exhibits a negative relationship. © 2010 The Author(s).
 
dc.description.naturepublished_or_final_version
 
dc.description.otherSpringer Open Choice, 21 Feb 2012
 
dc.identifier.citationJournal Of The Academy Of Marketing Science, 2011, v. 39 n. 5, p. 757-776 [How to Cite?]
DOI: http://dx.doi.org/10.1007/s11747-010-0229-y
 
dc.identifier.citeulike8180759
 
dc.identifier.doihttp://dx.doi.org/10.1007/s11747-010-0229-y
 
dc.identifier.eissn1552-7824
 
dc.identifier.epage776
 
dc.identifier.isiWOS:000294353600007
 
dc.identifier.issn0092-0703
2013 Impact Factor: 3.410
2013 SCImago Journal Rankings: 3.022
 
dc.identifier.issue5
 
dc.identifier.openurl
 
dc.identifier.scopuseid_2-s2.0-80052049070
 
dc.identifier.spage757
 
dc.identifier.urihttp://hdl.handle.net/10722/145100
 
dc.identifier.volume39
 
dc.languageEng
 
dc.publisherSpringer Netherlands
 
dc.publisher.placeNetherlands
 
dc.relation.ispartofJournal of the Academy of Marketing Science
 
dc.relation.referencesReferences in Scopus
 
dc.rightsThe Author(s)
 
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
 
dc.subjectBusiness-to-business relationships
 
dc.subjectFinancial performance
 
dc.subjectGlobal innovation generation
 
dc.subjectPharmaceutical industry
 
dc.subjectStrategic alliances
 
dc.titleGlobal innovation generation and financial performance in business-to-business relationships: The case of cross-border alliances in the pharmaceutical industry
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Sivakumar, K</contributor.author>
<contributor.author>Roy, S</contributor.author>
<contributor.author>Zhu, J</contributor.author>
<contributor.author>Hanvanich, S</contributor.author>
<date.accessioned>2012-02-21T05:44:45Z</date.accessioned>
<date.available>2012-02-21T05:44:45Z</date.available>
<date.issued>2011</date.issued>
<identifier.citation>Journal Of The Academy Of Marketing Science, 2011, v. 39 n. 5, p. 757-776</identifier.citation>
<identifier.issn>0092-0703</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/145100</identifier.uri>
<description.abstract>The past few decades have witnessed a significant increase in the number of cross-border strategic alliances among firms. We focus on the role of alliance expertise (alliance experience and diversity of partners) and alliance governance (horizontal vs. vertical alliances and joint venture vs. other alliances) in global innovation generation. We also examine the effect of these variables on the financial performance of the focal firm. The conceptual model is tested using an empirical analysis of cross-border alliances formed by U. S. pharmaceutical companies from 1985 to 2008. We find that while prior alliance experience has a positive association with global innovation generation, diversity of partners has a negative relationship. In addition, whether the alliance is horizontal or vertical has no bearing on the innovation generation, but joint ventures are associated with more global innovation generation than other types of alliances. Finally, as global innovation generation increases, financial performance increases up to a point but thereafter exhibits a negative relationship. &#169; 2010 The Author(s).</description.abstract>
<language>Eng</language>
<publisher>Springer Netherlands</publisher>
<relation.ispartof>Journal of the Academy of Marketing Science</relation.ispartof>
<rights>The Author(s)</rights>
<rights>Creative Commons: Attribution 3.0 Hong Kong License</rights>
<subject>Business-to-business relationships</subject>
<subject>Financial performance</subject>
<subject>Global innovation generation</subject>
<subject>Pharmaceutical industry</subject>
<subject>Strategic alliances</subject>
<title>Global innovation generation and financial performance in business-to-business relationships: The case of cross-border alliances in the pharmaceutical industry</title>
<type>Article</type>
<identifier.openurl>http://library.hku.hk:4551/resserv?sid=springerlink&amp;genre=article&amp;atitle=Global innovation generation and financial performance in business-to-business relationships: the case of cross-border alliances in the pharmaceutical industry&amp;title=Journal of the Academy of Marketing Science&amp;issn=00920703&amp;date=2011-10-01&amp;volume=39&amp;issue=5&amp; spage=757&amp;authors=K. Sivakumar, Subroto Roy, JianJun Zhu, &lt;i&gt;et al.&lt;/i&gt;</identifier.openurl>
<description.nature>published_or_final_version</description.nature>
<identifier.doi>10.1007/s11747-010-0229-y</identifier.doi>
<identifier.scopus>eid_2-s2.0-80052049070</identifier.scopus>
<relation.references>http://www.scopus.com/mlt/select.url?eid=2-s2.0-80052049070&amp;selection=ref&amp;src=s&amp;origin=recordpage</relation.references>
<identifier.volume>39</identifier.volume>
<identifier.issue>5</identifier.issue>
<identifier.spage>757</identifier.spage>
<identifier.epage>776</identifier.epage>
<identifier.eissn>1552-7824</identifier.eissn>
<identifier.isi>WOS:000294353600007</identifier.isi>
<publisher.place>Netherlands</publisher.place>
<description.other>Springer Open Choice, 21 Feb 2012</description.other>
<identifier.citeulike>8180759</identifier.citeulike>
<bitstream.url>http://hub.hku.hk/bitstream/10722/145100/1/fulltext.pdf</bitstream.url>
</item>
Author Affiliations
  1. University of New Haven
  2. The University of Hong Kong
  3. Hanvanich Financial LLC
  4. Lehigh University